(Q27852995)
Statements
1 reference
Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21. (English)
1 reference
April 2014
0 references
9
0 references
4
0 references
506-11
0 references